The Actinic Keratosis Market Research Report Forecast 2018-2026 is an important source of insightful data for market strategists. It presents the Actinic Keratosis industry overview with growth analysis and past & futuristic cost, income, demand and supply data (as relevant). The research analysts present a detailed representation of the value chain and its distributor analysis. This Actinic Keratosis market study gives complete data which improves the understanding.
Browse here for full report:
https://www.credenceresearch.com/report/actinic-keratosis-market
Market Insight:
Actinic keratosis (AK) is characterized by skin papules, macules or plaques resulting from prolonged exposure to harmful UV exposure and can result in squamous cell carcinoma. Risk of developing actinic keratosis increases with advancing age and is particularly higher in men as against women. About 5-20% of patients with actinic keratosis lesions develop malignant and potentially fatal squamous cell carcinomas.
Among the various treatment methods available, destructive therapies such as liquid nitrogen cryotherapy and surgical therapy constitute the gold standard for AK treatment. In 2015, cryotherapy was the most commonly sought treatment by clinicians. However, better clinical results of photodynamic therapy and growing preference for treatments based on drug-device combination have urged both caregivers and patients to opt for novel treatment methods that offer both advanced efficacy, aesthetic benefits and reduced risk of future malignancies. Topical treatment is a prolonged treatment and comparatively more effective than other treatments but patient compliance is the key issue that hinders the growth of this segment. Photodynamic therapy is the fastest growing treatment throughout the forecast period due to rising demand for non-invasive surgeries, and less treatment sessions are the key factors expected to assist this market
North America is the largest market for actinic keratosis treatment due to growing prevalence of AK, better public awareness about occurrence of AK and associated risk of squamous cell carcinoma. According to American Academy of Dermatology (AAD), approximately 60% of the Americans aged 40 year or above, Actinic Keratosis is predisposed to develop having at least 1 AK lesion. Actinic keratosis is precursors of squamous cell cancer. U.S. held the largest share in the actinic keratosis market in 2015 owing to current prevalence of actinic keratosis in the region.Asia Pacific is the fastest growing market for AK treatments. Australia has the highest prevalence of actinic keratosis ranging between 40% to 60% in adult population. Growing awareness in the region and rapid development in healthcare infrastructure and healthcare expenditure are the key growth factors in Asia Pacific actinic keratosis market.
This market is majorly driven by wide presence of generic drugs and is moderately competitive. Photodynamic therapy market has developed a niche with methyl aminolevulinate and aminolevulinic acid drugs. Galderma and DUSA pharmaceuticals are the chief players in this space. Some of the major players in the global actinic keratosis market are Tolmar Pharmaceuticals, Inc, DUSA Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Aqua Pharmaceuticals, LLC, Galderma SA, Perrigo Company plc, LEO Laboratories, Apotex and others.
Scope
Analysis of trends in the global Actinic Keratosis industry and interest for Actinic Keratosis in various regions, including Asia-Pacific, Europe, and North America
Market size and value of Actinic Keratosis used for commercial Actinic Keratosis from 2011 to 2017 and forecast for eight years up until 2026
The qualitative study of drivers and limitations of Actinic Keratosis market
Information on major market players such as BASF, Clariant, Cytec, SNF FloMin, Beijing Hengju chemical Group Corporation and Kemira among others.
Reasons to Buy
Gain up to date report and axnalysis about the global Actinic Keratosis market
Recognize key regions and countries that describe potential growth possibilities for the Actinic Keratosis market
Facilitate decision making by understanding the opportunities presented by the Actinic Keratosis market
Gain information about major players in the Actinic Keratosis market
Request Free Sample Report:
https://www.credenceresearch.com/sample-request/58011
Research methodology and delivery time
Credence Research has conducted in depth secondary research to arrive at key insights. Data collected from key public industry sources and publications have been scanned and analyzed impartially to present a clear picture of the industry. All recent developments which impact the sector dynamics have been captured and used to support the research hypothesis.
The report is available as the single-site single-user license. The delivery time for the electronic version of the report is 3 business days as each copy undergoes thorough quality check and is updated with the most recent information available.
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE, CA 95103, US
Email: sales@credenceresearch.com